Vertebroplasty and kyphoplasty device sales will expand continuously through 2035 because of a growing number of osteoporosis-related fractures while the world ages and patients increasingly seek minimally invasive spinal treatments.
Vertebral compression fractures (VCFs) get treated through these devices which provide swift pain reduction with added mobility benefits and stabilization to patient spinal structure. From 2025 to 2035 the market value for these devices is predicted to reach USD 1,674.1 million with a projected Compound Annual Growth Rate (CAGR) of 5.9% starting from USD 938.8 million in 2025.
The market sees increased adoption because image-guided surgical techniques improve along with new reimbursement structures for spinal procedures. The market growth of kyphoplasty devices increases as medical professionals recognize their ability to treat fractured backs by fixing deformities and increasing height of vertebral segments as well as improving clinical results.
The technology behind balloon inflation systems and bone cement injectors continues to improve for critical operational accuracy and lower procedural dangers and shorter recovery durations. Kyphoplasty continues to prove vital for VCF treatment in medical facilities because healthcare providers adopt evidence-based procedures for this segment particularly in patient populations experiencing aging-related and osteoporotic health issues.
Key Market Metrics
| Metric | Value |
|---|---|
| Industry Size (2025E) | USD 938.8 million |
| Industry Value (2035F) | USD 1,674.1 million |
| CAGR (2025 to 2035) | 5.9% |
The vertebroplasty and kyphoplasty devices market consists of product segments yet kyphoplasty devices have become the standard solution for minimally invasive spinal stabilization procedures. The inflatable bone tamps and delivery cannulas along with bone cement kits form part of these medical tools to provide improved anatomical restoration and procedural accuracy.
The medical community prefers kyphoplasty devices today because they treat multi-level fractures together with acute vertebral collapse while providing better outcomes alongside reduced complications. Medical professionals are using these products because of mounting clinical proof and their improved designs which shorten surgery durations and reduce patients' hospitalization periods.
The North American region dominated the global market owing to the highly developed healthcare infrastructure and higher adoption of minimally invasive spinal procedures. Due to increasing osteoporosis incidence and positive insurance coverage limits in the USA and Canada, kyphoplastyprocedure volumes are accelerating.
From hospitals and outpatient surgical centers to image guided systems and next-gen kyphoplasty tools, everyone is working hard to ensure good outcomes and shorter recovery times. Also, there is good clinical education and significant presence of device manufacturer activity in the region.
Steady growth across Europe is accelerated by its ageing population, greater knowledge of spine-care and improved access to specialist orthopedic care. Countries such as Germany, France, and Italy are now including kyphoplasty as part of standard treatment for vertebral fractures.
European health systems are investing in the training of surgeons and minim-invasive technologies to face the burden of postmenopausal and corticosteroid-induced osteoporosis. Local manufacturers are also benefiting from regulatory support and innovation grants that are helping to improve device design and procedural efficiency.
The high growth potential in the Asia-Pacific region is due to increased urbanization, normal aging of the population, and increased access to spine care services, as this region has emerged as one of the key growth regions. In countries such as China, Japan and South Korea, the number of osteoporotic fractures has been increasing, so that more hospitals have been shifting to kyphoplasty because it is safer than open surgery.
While public health initiatives and increasing private sector investments are boosting surgical capabilities in both urban and semi-urban centres. Regional players are also working on budgetary, portable kyphoplasty devices that are intended for price-sensitive markets.
Reimbursement Uncertainty and Procedural Risks
Both vertebroplasty and kyphoplasty devices market have encountered challenges with reimbursement policies and procedural risk concerns. Although these minimally invasive techniques represent effective treatment options for vertebral compression fractures, both inconsistent insurance coverage across regions, particularly for vertebroplasty, limits procedural volumes. Additionally, concerns about cement extravasation, adjacent vertebral body fractures, and postoperative pain have fostered scepticism by some physicians.
The requirement for specialized imaging functions and surgical experience in addition to elevate operational costs and lessen the wide dissemination to smaller care settings. These issues lead to clinical hesitancy and inconsistent worldwide adoption, despite increasing interest in no/low pain relief in OPO.
Aging Population, Minimally Invasive Preference, and Technological Advancements
the demand for vertebroplasty and kyphoplasty devices is fueled mainly by the increasing elderly population and the growing incidence of spine cancer that require this type of surgical treatments, in spite of regulatory and clinical challenges. Patients and doctors are increasingly choosing minimally invasive procedures rather than open surgery for shorter recovery times and fewer complications.
The safety and precision of the technique is increasing due to technological advancements in the control of bone cement viscosity, balloon-assisted vertebral height restoration, and image-guided navigation systems. With hospital systems increasingly focused on outpatient care and early mobility, these devices will be key to both pain management and structural restoration of the spinal column through aging and trauma states of care.
The period from 2020 to 2024 will be dominated by the need for increased emphasis on osteoporosis treatment and rapid surgical recovery. Though kyphoplasty became more favored because of its advantages of restoring vertebral height, vertebroplasty was still used for early pain relief. But cost sensitivity and reimbursement variability slowed expansion in smaller and public healthcare centers.
Between 2025 and 2035, the market will move toward advanced navigation-assisted procedures, bioresorbable cements, and robotic-assisted vertebral augmentation. Growing outpatient spine clinics, and ambulatory surgical unit presentations, as well as real-time imaging tools availability and aesthetic delivery precision and having burdened demographic trends across North America, Europe and Asia-Pacific will fuel the market demand.
Market Shifts: Comparative Analysis (2020 to 2024 vs. 2025 to 2035)
| Market Factor | 2020 to 2024 |
|---|---|
| Regulatory Landscape | Region-specific device approvals and reimbursement scrutiny. |
| Technological Advancements | Manual cement injectors and balloon inflation tools. |
| Sustainability Trends | Minimal focus on single-use device waste. |
| Market Competition | Led by orthopedic giants and spine-specialty device makers. |
| Industry Adoption | Common in orthopedic hospitals and trauma centers. |
| Consumer Preferences | Demand for fast pain relief and early mobility post-surgery. |
| Market Growth Drivers | Boosted by osteoporosis prevalence and spine fracture treatment trends. |
| Market Factor | 2025 to 2035 |
|---|---|
| Regulatory Landscape | Streamlined cross-border device approvals and outcome-based reimbursement frameworks. |
| Technological Advancements | Growth in robotic-assisted navigation, advanced cement delivery systems, and bone regeneration devices. |
| Sustainability Trends | Shift to reusable instruments, recyclable packaging, and eco-friendly surgical kits. |
| Market Competition | Entry of robotic surgery firms, outpatient spinal care startups, and bio-implant innovators. |
| Industry Adoption | Expands to outpatient clinics, geriatric centers, and remote healthcare systems. |
| Consumer Preferences | Shift to less invasive, precision-guided, and long-term biomechanical stability solutions. |
| Market Growth Drivers | Accelerated by minimally invasive surgical innovation, outpatient care growth, and aging population needs. |
North America dominates the vertebroplasty and kyphoplasty device market share in terms of the highest procedure volume, mature reimbursement policies, and a large pool of aging population. The population's increasing life expectancy has led to an increase in osteoporotic fractures and end-stage chronic back pain which has caused a rise in the demand for minimally invasive spinal procedures.
Balloon kyphoplasty systems and targeted cement delivery devices that provide more control and improved vertebral height restoration are being increasingly introduced in USA hospitals and outpatient centers. Procedural accuracy is also being supported by innovation in radiopaque bone cements and steerable cannulas.
| Country | CAGR (2025 to 2035) |
|---|---|
| USA | 5.7% |
In the UK, the market continues to grow steadily as the NHS strives to reduce hospital stay and enhance outcomes for vertebral compression fractures. Vertebroplasty and kyphoplasty are increasingly done in the office, particularly for older patients with decreased bone density.
Clinicians in the UK prefer systems that balance rapid cement delivery with low-radiation exposure. Market acceptance is further increased by the growing usage of image guided systems and advances in biocompatible materials.
| Country | CAGR (2025 to 2035) |
|---|---|
| UK | 5.5% |
Countries such as Germany, France, and Italy remain good markets in the European Union for vertebroplasty and kyphoplasty devices. The increasing procedural volumes can be attributed to high awareness regarding the osteoporotic fracture treatment followed by the well-established healthcare infrastructure.
Low-viscosity fast-setting bone cements and advanced balloon technologies are proliferating in the hands of device manufacturers in the EU to augment vertebral stabilization. Clinical data supporting early intervention to prevent spinal deformity and functional decline is also driving the market.
| Region | CAGR (2025 to 2035) |
|---|---|
| European Union | 5.9% |
Japan’s marketis increasing with the country’s aging populace and growing identification of vertebral contractions in elderly patients. Japanese hospitals are implementing image-guided, minimally invasive systems that minimize recovery and hinder the dependence on opioid-based anaesthesia.
Local medical device manufacturers are engaged in compact, precision-controlled injection systems and cement formulations that are appropriate for the smaller bone structures that are more prevalent in the region’s patient population.
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 5.6% |
South Korea has also shown an impressive increase in vertebroplasty and kyphoplasty devices with the incrementing accessibility to the health care services, along with the increasing awareness of Osteoporosis and meager in elective spine procedures help boost growth in this region.
Integrated imaging and navigation systems being adopted at South Korean hospitals are generating benefits in accuracy and reduced complications. Local companies are also emerging with affordable options and customizable kits, improving accessibility for public and private care facilities.
| Country | CAGR (2025 to 2035) |
|---|---|
| South Korea | 6.2% |
Global Vertebroplasty/Kyphoplasty Devices Market is projected to grow due to increase in vertebral compression fractures (VCFs) due to osteoporosis, trauma, or spinal tumors. These minimally invasive procedures provide immediate pain relief and stabilization of the spine enabling patients (especially elderly) to facilitate their quality of life. By product type, kyphoplasty device type accounts for the largest market share in both product type segments due to their ability to restore vertebral body height and to correct the kyphotic deformity.
The capacity to create cavity during infusion helps in avoidance of the cement leakage while acceptable restoration can be got during kyphoplasty, which assists the medical professionals to obtain the extensive diameter through the needle through kyphoplasty as compared to vertebroplasty which is the reason behind the overall preference of kyphoplasty to traditional vertebroplasty among medical professionals.
With the number of elderly individuals who could potentially receive treatment growing from the widespread dispersion of geriatric demographics across North America, Europe, and Asia-Pacific, along with increasing recognition of the capability amenable to less invasive spinal surgical techniques, kyphoplasty devices continue to capitalize on their influence on the increasingly heated discussions surrounding surgical changes within spine care.
| Product Type | Market Share (2025) |
|---|---|
| Kyphoplasty Devices | 56.8% |
Working on painful vertebral compression fractures along with an advanced treatment option kyphoplasty devices lead the product segment. This includes insertion of an inflatable balloon tamp to create the cavity (within the collapsed vertebra) and inject the bone cement. The balloon restores vertebral height, re-establishes curvature of the spine, and off-loads pressure on adjacent vertebrae.
This approach markedly reduces complications associated with "extravasation" of uncontained cement, a widely reported issue with traditional vertebroplasty approaches. This combination makes kyphoplasty devices increasingly common in hospitals and outpatient centers as structural correction and rapid recovery in patients with osteoporosis-related fractures becomes essential.
Kyphoplasty is preferred by clinicians because it is more reproducible and leads to better outcomes in elderly and high-risk patients. Research suggests that kyphoplasty patients tend to have higher pain-score reductions and shorter hospital stays, and return to their feet soon afterwards compared with those receiving vertebroplasty.
Manufacturers are still innovating in balloon design, bone cement formulation and image-guidance systems that increase the precision and accessibility of kyphoplasty. With growing interest in less invasive spinal interventions with better outcomes, kyphoplasty devices represent the most common and investigated vertebral-fracture treatment worldwide.
The vertebroplasty and kyphoplasty devices market because it forms an essential piece of spinal intervention procedures which focus on fixing vertebral compression fractures from osteoporosis and trauma and disease such as metastasis. These two procedures do percutaneous injections to utilize bone cement as well as balloon-assisted height restoration which both stabilize vertebrae, minimize pain and correct spinal alignment.
The market experiences growing demand because of three factors: an aging population, more cases of osteoporosis and patient preferences toward image-guided outpatient’s procedures. Competing players focus on precise delivery systems and innovative balloons and control cement viscosity as well as radiopaque properties and navigation compatibility with both fluoroscopic and CT imaging.
Market Share Analysis by Company
| Company Name | Estimated Market Share (%) |
|---|---|
| Medtronic plc | 22-26% |
| Stryker Corporation | 17-21% |
| Merit Medical Systems, Inc. | 12-16% |
| Johnson & Johnson ( DePuy Synthes ) | 9-13% |
| IZI Medical Products | 7-11% |
| G21 S.r.l. | 6-10% |
| Other Companies (combined) | 18-26% |
| Company Name | Key Offerings/Activities |
|---|---|
| Medtronic plc | Launched the Kyphon ™ Balloon Kyphoplasty System with dual-lumen inflation and high-viscosity cement for vertebral height restoration in 2025. |
| Stryker Corporation | Released the iVAS Elite System with enhanced radiopaque cement and steerable balloon catheters for precise fracture targeting in 2024. |
| Merit Medical Systems | Expanded the STAR™ Tumor Ablation and SpineSTAR ® delivery systems for oncologic spine intervention and targeted vertebral stabilization in 2025. |
| DePuy Synthes (J&J) | Rolled out Vertecem ™ V+ Cement and Vertebral Balloon System for kyphoplasty procedures with integrated mixing and delivery in 2024. |
| IZI Medical Products | Introduced minimally invasive vertebroplasty kits with bone needle sets and pressure-controlled injection systems in 2024. |
| G21 S.r.l. | Developed G21 Teknimed Vertebral Augmentation System with thermal control cement and MRI-compatible delivery options in 2025. |
Key Company Insights
Medtronic plc
Medtronic leads the vertebroplasty and kyphoplasty devices market with its well-established Kyphon™ platform. It offers precision-engineered balloon catheters and advanced bone cements, optimized for safety, visibility, and pain relief in both hospital and outpatient settings.
Stryker Corporation
Stryker delivers innovative solutions with its iVAS Elite system, featuring intuitive control, low-leakage cement formulations, and ergonomic design. Its systems support accurate deployment in complex spinal anatomies and osteoporotic fractures.
Merit Medical Systems, Inc.
Merit Medical offers a broad suite of tools for spine intervention, including targeted ablation and vertebral stabilization systems. Its minimally invasive devices are favored in oncology and pain management practices for treating metastatic spine disease.
Johnson & Johnson (DePuySynthes)
DePuySynthes provides comprehensive vertebral augmentation systems integrating cement mixers, delivery injectors, and customizable balloon sizes. The company emphasizes simplified workflows and proven biocompatibility in cement solutions.
IZI Medical Products
IZI specializes in cost-effective, disposable kits for vertebroplasty procedures, offering radiopaque bone cements and standardized injection systems. Its tools are widely used in interventional radiology and outpatient spine care clinics.
G21 S.r.l.
G21 brings European engineering to the market with highly adaptable vertebral augmentation kits and advanced cements featuring controlled exothermic profiles. Its systems prioritize safety, thermal regulation, and easy adoption across varied clinical settings.
Other Key Players (18-26% Combined)
Numerous regional and specialty device manufacturers contribute to the vertebroplasty and kyphoplasty devices market with customized offerings, distribution partnerships, and niche clinical capabilities:
The overall market size for the vertebroplasty and kyphoplasty devices market was USD 938.8 million in 2025.
The vertebroplasty and kyphoplasty devices market is expected to reach USD 1,674.1 million in 2035.
The increasing incidence of vertebral compression fractures, rising aging population, and growing adoption of minimally invasive spine procedures using kyphoplasty devices fuel the vertebroplasty and kyphoplasty devices market during the forecast period.
The top 5 countries driving the development of the vertebroplasty and kyphoplasty devices market are the USA, UK, European Union, Japan, and South Korea.
Kyphoplasty devices lead market growth to command a significant share over the assessment period.
Explore Therapeutic Device Insights
Vertebroplasty And Kyphoplasty Devices Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
